ASNC 2017

401 - Controversies in Clinical Cardiology and Cardiac Imaging

Sep 17, 2017 8:00am ‐ Sep 17, 2017 9:30am


Description

Moderator: Prem Soman, MD, PhD, FASNC; Viviany R. Taqueti, MD

Learning Objectives:

  • Understand that in 4000 sequential cardiac PETs, the Coronary Flow Capacity combining stress perfusion and CFR uniquely identifies patients for whom PCI/CABG significantly reduces MI and mortality by 54% over long term follow up and eliminates 70% to 90% of low benefit invasive procedures or other tests including patients with known or advanced CAD with low risk disease by PET that are optimally treated medically
  • To become familiar with the etiology of LV ejection fraction decline in patients receiving cardiotoxic chemotherapy

08:00 - 08:12 - Debate 1 - Breakthrough: Novel approaches for Early Detection of Chemotherapy Cardiotoxicity
W. Gregory Hundley, MD

08:12 - 08:24 - Debate 1 - Controversy: What Would it take for Novel Markers of Cardiac Toxicity to Replace Ejection Fraction
Indu Poornima, MD

08:24 - 08:30 - Discussion

08:30 - 08:42 - Debate 2 - Breakthrough: FDG Imaging of Cardiac and Vascular Inflammation
Ahmed Tawakol, MD

08:42 - 08:54 - Debate 2 - Controversy: Is FDG Imaging the Be-all and End-all?
Robert J. Gropler, MD, MASNC

08:54 - 09:00 - Discussion

09:00 - 09:12 - Debate 3 - Breakthrough: Noninvasive Quantification of Coronary Flow Reserve
Marcelo Di Carli, MD

09:12 - 09:24 - Debate 3 - Controversy: Is Coronary Flow Reserve Good Enough to Guide Management in CAD?
K. Lance Gould, MD

09:24 - 09:30 - Discussion

Moderator(s):

Speaker(s):

You must be logged in and own this session in order to post comments.